Innovotech, Inc. (IOT.V)
0.08
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 16:00
Innovotech Debt to Equity Ratio : 0.0642 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0642 |
| March 31, 2026 | 0.0506 |
| December 31, 2025 | 0.0446 |
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.0998 |
| June 30, 2024 | 0.1372 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.0153 |
| December 31, 2022 | 0.035 |
| September 30, 2022 | 0.0523 |
| June 30, 2022 | 0.0742 |
| March 31, 2022 | 0.0886 |
| December 31, 2021 | 0.1038 |
| September 30, 2021 | 0.0212 |
| June 30, 2021 | 0.0207 |
| March 31, 2021 | 0.0254 |
| December 31, 2020 | 0.031 |
| September 30, 2020 | 0.243 |
| June 30, 2020 | 1.244 |
| Date | Value |
|---|---|
| March 31, 2020 | -5.814 |
| December 31, 2019 | 1.019 |
| September 30, 2019 | 1.054 |
| June 30, 2019 | 1.321 |
| March 31, 2019 | 1.238 |
| December 31, 2018 | 1.070 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | |
| December 31, 2017 | 0.00 |
| September 30, 2017 | -0.7055 |
| June 30, 2017 | -1.236 |
| March 31, 2017 | -0.8428 |
| December 31, 2016 | -0.8135 |
| September 30, 2016 | -0.1276 |
| June 30, 2016 | -0.1234 |
| March 31, 2016 | -0.1073 |
| December 31, 2015 | -0.1122 |
| September 30, 2015 | -0.1181 |
| June 30, 2015 | -0.1242 |
| March 31, 2015 | -0.1362 |
| December 31, 2014 | -0.8037 |
| September 30, 2014 | -0.121 |
| June 30, 2014 | -0.7245 |
| March 31, 2014 | -0.0721 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Arch Biopartners, Inc. | -0.7494 |
| Kane Biotech, Inc. | -1.352 |
| Quest PharmaTech, Inc. | 0.0378 |
| BriaCell Therapeutics Corp. | 0.00 |
| Vaxil Bio Ltd. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 3.585M |
| Total Liabilities (Quarterly) | 0.9938M |
| Shareholders Equity (Quarterly) | 2.543M |
| Current Ratio | 2.066 |
| Net Debt Paydown Yield | -0.71% |